

Curious how Fluticasone/Vilanterol (Breo Ellipta) works in your body? This plain-English guide explains the mechanism of action, how long it takes to work, and what makes it different from other inhalers.
If you've been prescribed Fluticasone/Vilanterol (brand name Breo Ellipta), you might be wondering: what exactly does this medication do inside my lungs? How does one puff a day keep my breathing on track?
This guide breaks down the mechanism of action in plain language — no medical jargon required.
Fluticasone/Vilanterol is a combination of two drugs that work together to address the two main problems in asthma and COPD:
When you have asthma or COPD, the lining of your airways becomes inflamed — swollen, irritated, and producing excess mucus. This makes the airways narrower and harder to breathe through.
Fluticasone furoate is an inhaled corticosteroid (ICS). When you breathe it in, it lands on the cells lining your airways and does several things:
Think of fluticasone as a fire extinguisher for your airways. It doesn't just put out the fire — it prevents it from starting in the first place.
Even after inflammation is reduced, the muscles around your airways can still tighten, making it hard to breathe. That's where vilanterol comes in.
Vilanterol is a long-acting beta2-adrenergic agonist (LABA). Here's what that means in simple terms:
Think of vilanterol as opening a window that's been stuck shut. It physically widens the breathing passages.
You could take an anti-inflammatory steroid alone, or a bronchodilator alone — and many people do. But research shows that combining the two is more effective than using either one by itself, especially for moderate-to-severe asthma and COPD.
Here's why: inflammation and muscle tightening feed off each other. Inflamed airways are more likely to spasm, and tight airways trap mucus, which worsens inflammation. By tackling both problems at once, Fluticasone/Vilanterol breaks this cycle more effectively.
There's also a biological synergy — corticosteroids increase the number of beta2 receptors on airway muscle cells, making vilanterol work better. And vilanterol activates certain pathways that enhance the anti-inflammatory effects of fluticasone. They genuinely make each other more effective.
This is an important distinction:
Don't be discouraged if you don't feel a dramatic difference on day one. The medication is working — it's just that reducing chronic inflammation takes time.
Important: Fluticasone/Vilanterol is not a rescue inhaler. If you're having a sudden asthma attack or COPD flare-up, use your short-acting rescue inhaler (like albuterol). Breo Ellipta is for daily prevention, not emergency relief.
Each dose of Fluticasone/Vilanterol is designed to last 24 hours. That's why you only need to take it once a day — a real advantage over older inhalers that require two or three doses daily.
Vilanterol provides bronchodilation for a full 24 hours, and the anti-inflammatory effects of fluticasone furoate are sustained throughout the day as well. Taking it at the same time each day helps maintain steady drug levels in your airways.
There are several ICS/LABA combination inhalers on the market. Here's how Breo Ellipta compares:
Most competing inhalers — like Advair (Fluticasone/Salmeterol), Symbicort (Budesonide/Formoterol), and Dulera (Mometasone/Formoterol) — require twice-daily dosing. Breo Ellipta's once-daily schedule is simpler and can improve adherence. If you struggle to remember medications, one dose a day is easier to stick with.
The Ellipta inhaler is a dry powder inhaler with a simple design: open the cover, breathe in, close the cover. There's no shaking, no priming, and no coordinating a button press with your breath (like with metered-dose inhalers). It also has a built-in dose counter so you always know how many doses are left.
Don't confuse the fluticasone in Breo Ellipta with the fluticasone in Advair. Breo Ellipta uses fluticasone furoate, a newer formulation with a longer duration of action. Advair uses fluticasone propionate, which requires twice-daily dosing. They're related but not identical.
Similarly, vilanterol is a newer LABA than salmeterol (used in Advair). Vilanterol has a faster onset and longer duration, which supports the once-daily dosing.
For information on alternatives, see our guide on alternatives to Fluticasone/Vilanterol.
Fluticasone/Vilanterol works by fighting inflammation and opening your airways at the same time. The two ingredients complement each other, and the once-daily dosing makes it one of the most convenient options for managing asthma and COPD.
The key to getting the most out of it is consistency — use it every day, at the same time, even when you feel well. If you want to learn more about the medication, read our full overview: What is Fluticasone/Vilanterol? If you're having trouble finding it at your pharmacy, Medfinder can help you locate it nearby.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.